{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:50:00Z","timestamp":1760784600717,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.arcped.2018.12.002","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T19:49:31Z","timestamp":1547063371000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["French expert opinion for the management of juvenile dermatomyositis"],"prefix":"10.1016","volume":"26","author":[{"given":"B.","family":"Bader-Meunier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gitiaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bughin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Musset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bourrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"371","key":"10.1016\/j.arcped.2018.12.002_bib0290","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"28","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2018.12.002_bib0295","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","article-title":"Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis","volume":"7","author":"Robinson","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"Martin","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0305","first-page":"782","article-title":"Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients","volume":"28","author":"Mathiesen","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0310","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) clinical characteristics of children recruited within the first 5\u00a0years","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.arcped.2018.12.002_bib0315","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: clinical characteristics of 79\u00a0children","volume":"25","author":"Pachman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0320","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr.22142","article-title":"Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry","volume":"66","author":"Robinson","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0335","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","article-title":"A systematic review of juvenile-onset clinically amyopathic dermatomyositis","volume":"157","author":"Gerami","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0340","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New Engl J Med"},{"key":"10.1016\/j.arcped.2018.12.002_bib0345","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0350","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/annrheumdis-2013-203279","article-title":"In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity","volume":"73","author":"Schwartz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2018.12.002_bib0355","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/ard.2010.137968","article-title":"Cardiac dysfunction in juvenile dermatomyositis: a case-control study","volume":"70","author":"Schwartz","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2018.12.002_bib0360","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/acr.22014","article-title":"Pulmonary function tests in idiopathic inflammatory myopathy: association with clinical parameters in children","volume":"65","author":"Prestridge","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0365","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/ket380","article-title":"Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients","volume":"53","author":"Mathiesen","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0370","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ppul.22742","article-title":"The lung is involved in juvenile dermatomyositis","volume":"48","author":"Pouessel","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0375","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.22782","article-title":"Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration fromchronic endarteropathy","volume":"57","author":"Mamyrova","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2018.12.002_bib0380","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/annrheumdis-2013-203396","article-title":"Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease","volume":"74","author":"Varsani","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2018.12.002_bib0385","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.23012","article-title":"International consensus on a proposed score system for muscle biopsy evaluation in patients with JDM, for potential use in clinical trials","volume":"57","author":"Wedderburn","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2018.12.002_bib0390","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/ajr.161.2.8333378","article-title":"MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings","volume":"161","author":"Hernandez","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0395","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","article-title":"Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis","volume":"73","author":"Malattia","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2018.12.002_bib0400","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/rheumatology\/keq430","article-title":"Association between nail-fold capillary findings and disease activity in dermatomyositis","volume":"50","author":"Mugii","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0405","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis","volume":"50","author":"Schmeling","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0410","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pediatrneurol.2014.04.013","article-title":"Diagnostic yield of electromyography in children with myopathic disorders","volume":"51","author":"Ghosh","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0415","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0420","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.arcped.2018.12.002_bib0425","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein","volume":"36","author":"Espada","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0430","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2018.12.002_bib0435","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","article-title":"Anti-melanoma differentiation-associated gene 5\u00a0antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis","volume":"158","author":"Kobayashi","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2018.12.002_bib0440","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","article-title":"Anti-MDA5\u00a0autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study","volume":"16","author":"Tansley","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arcped.2018.12.002_bib0445","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","article-title":"Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2\u00a0autoantibody status and age at disease onset","volume":"53","author":"Tansley","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0450","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/rheumatology\/kex516","article-title":"Muscle ischaemia associated with NXP2\u00a0autoantibodies: a severe subtype of juvenile dermatomyositis","volume":"57","author":"Aouizerate","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0455","first-page":"470","article-title":"Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis","volume":"55","author":"Gitiaux","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0460","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with Myositis-Specific Autoantibodies Aid Prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0465","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11926-014-0464-1","article-title":"Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies","volume":"16","author":"Tansley","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.arcped.2018.12.002_bib0470","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Evidence based recommandations for diagnosis and treatment of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2018.12.002_bib0475","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2018.12.002_bib0480","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/acr.20269","article-title":"Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis","volume":"62","author":"Rouster-Stevens","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.arcped.2018.12.002_bib0485","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s10067-015-3065-0","article-title":"The efficacy of tacrolimus in patients with refractory dermatomyositis\/polymyositis: a systematic review","volume":"34","author":"Ge","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0490","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Rei","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0495","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.arcped.2018.12.002_bib0500","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2018.12.002_bib0505","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490\u00a0patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0515","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2018.12.002_bib0520","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","article-title":"Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool","volume":"53","author":"Sanner","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0525","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0530","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the childhood myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2018.12.002_bib0535","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0540","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/rheumatology\/kem179","article-title":"The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy","volume":"46","author":"Huber","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0545","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/acr.22867","article-title":"Comparison of the utility and validity of three scoring tools to measure skin involvement in patients with Juvenile Dermatomyositis","volume":"68","author":"Campanilho-Marques","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0550","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.23313","article-title":"Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats","volume":"59","author":"Huber","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.arcped.2018.12.002_bib0555","first-page":"118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arcped.2018.12.002_bib0560","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"Lazarevic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2018.12.002_bib0565","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrrheum.2012.165","article-title":"Paediatric rheumatic disease: Defining clinically inactive disease in juvenile dermatomyositis","volume":"8","author":"Luca","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.arcped.2018.12.002_bib0570","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/acr.20280","article-title":"The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X18302628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X18302628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:51:36Z","timestamp":1760539896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X18302628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0929693X18302628"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2018.12.002","relation":{},"ISSN":["0929-693X"],"issn-type":[{"type":"print","value":"0929-693X"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French expert opinion for the management of juvenile dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}